Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
Consistency is everything
Amgen, the pharmaceutical company that produces Enbrel in the United States, still has patent protection over the drug, meaning other companies cannot yet make biosimilar versions of the medication that tend to be less expensive. There is no Enbrel biosimilar (comparable to a generic) yet
Researchers study it for two main goals: helping the body shrink fat cells and raising NAD+ levels inside cells without cutting appetite
Its main job is to keep you and others safe from accidental needlesticks
US$ 21.27
US$ 27.27
US$ 27.53
US$ 27.67
US$ 28.95
